862 Spam-Free Article(s) Found
Symbol Name Last Close Mkt Cap DailyStocks'
Our DailyStocks’ Rating System is a proprietary algorithm that combines the vote of the investor community and legendary trader Richard Dennis’ Turtle Trader System and the System Rules of the Turtle Traders Each day, we generate Buy, Sell, Uptrend or Downtrend signals for 3000 Stocks in the U.S. Markets.
Vote Now!
Wednesday’s Close
MRK Merck & Company, Inc. $70.42 $187.28B N/A
Article Searches
The Best Hep C Drug Stock to Buy in 2017 https://www.fool.com/investing/2017/06/08/the-best-hep-c-drug-stock-to-buy-in-2017.aspx?source=iedfolrf0000001 Jun 08, 2017 - Each drugmaker has unique opportunities, but only one can come out on top.
Why BeiGene Soared 56.6% In July https://www.fool.com/investing/2017/08/09/why-beigene-soared-566-in-july.aspx?source=iedfolrf0000001 Aug 09, 2017 - The company inked a trans-formative deal with biotech behemoth Celgene last month.
10 Rock-Solid Reasons Johnson & Johnson's Near-Term Future Looks Bright https://www.fool.com/investing/2017/09/17/10-rock-solid-reasons-johnson-johnsons-near-term-f.aspx?source=iedfolrf0000001 Sep 17, 2017 - There's more good news that you might think for the healthcare giant in the coming quarters.
1 Great Biotech Stock You Have Never Heard Of https://www.fool.com/investing/2017/09/29/1-great-biotech-stock-you-have-never-heard-of.aspx?source=iedfolrf0000001 Sep 29, 2017 - Big pharma companies have thrown hundreds of millions of dollars at this small biotech. Should retail investors follow suit?
Stock Market News for August 27, 2015 http://www.zacks.com/stock/news/187975/stock-market-news-for-august-27-2015?cid=CS-ZC-FT-187975 Aug 27, 2015 - Benchmarks scored a multi-record percentage gain on Wednesday following strong durable-goods report and comments from a Fed official that a September rate hike seems inappropriate
Incyte & Hengrui to Develop Anti-PD-1 Monoclonal Antibody http://www.zacks.com/stock/news/188899/incyte-hengrui-to-develop-anti-pd-1-monoclonal-antibody?cid=CS-ZC-FT-188899 Sep 03, 2015 - Incyte (INCY) signs an agreement with Hengrui to develop and commercialize an anti-PD-1 monoclonal antibody, SHR-1210.
Company News for September 22, 2015 http://www.zacks.com/stock/news/190890/company-news-for-september-22-2015?cid=CS-ZC-FT-190890 Sep 22, 2015 - Companies in the News are: ATML,P,ANIP,MRK,VLKAY
Stock Market News for September 23, 2015 http://www.zacks.com/stock/news/191065/stock-market-news-for-september-23-2015?cid=CS-ZC-FT-191065 Sep 23, 2015 - Selloff in commodity, auto and biotech stocks dragged benchmarks lower on Tuesday
Merck & Co (MRK) Q4 2015 Results - Earnings Call Webcast http://seekingalpha.com/article/3858646-merck-and-co-mrk-q4-2015-results-earnings-call-webcast?source=feed_all_articles Feb 03, 2016 -
Merck & Co. (MRK) Kenneth C. Frazier on Q1 2016 Results - Earnings Call Transcript http://seekingalpha.com/article/3971837-merck-and-co-mrk-kenneth-c-frazier-q1-2016-results-earnings-call-transcript?source=feed_all_articles May 05, 2016 - Merck & Co., Inc. (NYSE:MRK)Q1 2016 Earnings CallMay 05, 2016 8:00 am ETExecutivesTeri Loxam - Vice President, Investor RelationsKenneth C. Frazier - Chairman, President & Chief Executive OfficerRober

Pages: 1234567891011...87

<<<Page 6>